| Dylan Doss, DO | |
|
16857 E Saguaro Blvd, Fountain Hills, AZ 85268-6616 | |
| (480) 626-9578 | |
| (920) 241-1167 |
| Full Name | Dylan Doss |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 16857 E Saguaro Blvd, Fountain Hills, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609308006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 008350 (Arizona) | Primary |
| Entity Name | Fountain Hills Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649926536 PECOS PAC ID: 1658768817 Enrollment ID: O20220419000482 |
News Archive
The incidence of childhood leukaemia in Britain increased dramatically during the twentieth century. The increase has mainly affected the under-five age group, in whom the risk increased by more than 50 per cent during the second half of the century alone.
Take extra care at your Memorial Day, Fourth of July and Labor Day celebrations this year by ensuring that accidents do not interfere with summer fun. Dr. Roger Yurt, director of the Hearst Burn Center of NewYork-Presbyterian Hospital/Weill Cornell Medical Center, recommends the following safety tips to avoid burns from barbecues, fireworks and other routine activities that can pose a hazard this season.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.
University Hospitals (UH) Case Medical Center has become the first hospital in Northeast Ohio and 19th in the nation to achieve The Joint Commission's standards for Comprehensive Stroke Center Certification, joining an elite group of providers focused on complex stroke care.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dylan Doss, DO 16857 E Saguaro Blvd, Fountain Hills, AZ 85268-6616 Ph: (480) 626-9578 | Dylan Doss, DO 16857 E Saguaro Blvd, Fountain Hills, AZ 85268-6616 Ph: (480) 626-9578 |
News Archive
The incidence of childhood leukaemia in Britain increased dramatically during the twentieth century. The increase has mainly affected the under-five age group, in whom the risk increased by more than 50 per cent during the second half of the century alone.
Take extra care at your Memorial Day, Fourth of July and Labor Day celebrations this year by ensuring that accidents do not interfere with summer fun. Dr. Roger Yurt, director of the Hearst Burn Center of NewYork-Presbyterian Hospital/Weill Cornell Medical Center, recommends the following safety tips to avoid burns from barbecues, fireworks and other routine activities that can pose a hazard this season.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.
University Hospitals (UH) Case Medical Center has become the first hospital in Northeast Ohio and 19th in the nation to achieve The Joint Commission's standards for Comprehensive Stroke Center Certification, joining an elite group of providers focused on complex stroke care.
› Verified 2 days ago
Dr. Douglas Robinson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10624 N Crestview Dr, Fountain Hills, AZ 85268 Phone: 202-489-3622 | |
Sandeep Yarlagadda, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9700 N Saguaro Blvd, Fountain Hills, AZ 85268 Phone: 509-715-1330 | |
Dr. Chukwuemeka N Ezeume, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9700 N Saguaro Blvd, Fountain Hills, AZ 85268 Phone: 602-671-7990 | |
Dr. Parminder Singh Sidhu, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16838 E Palisades Blvd Ste 153, Fountain Hills, AZ 85268 Phone: 480-816-3131 Fax: 844-207-3461 | |
Jyoti R Patel, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13620 N Saguaro Blvd, Suite 100, Fountain Hills, AZ 85268 Phone: 480-816-3131 Fax: 480-816-3136 | |
Jodi K Novak, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16838 E Palisades Blvd Ste 153, Fountain Hills, AZ 85268 Phone: 480-816-3131 Fax: 844-207-3461 |